Literature DB >> 14611719

Interleukin-25 (or IL-17E): a new IL-17 family member with growth factor/inflammatory actions.

D Kempuraj, S Frydas, P Conti, K Kandere- Grzybowska, W Boucher, R Letourneau, B Madhappan, S H Huang, K Sugimoto, N G Papadopoulou, S Christodoulou, T C Theoharides.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14611719     DOI： 10.1177/039463200301600301

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN： 0394-6320            Impact factor:   3.219


× No keyword cloud information.
  3 in total

1.  Interleukin-25 enhances the capacity of mesenchymal stem cells to induce intestinal epithelial cell regeneration.

Authors:  Jingling Su; Chenxi Xie; Yanyun Fan; Weizi Cheng; Yiqun Hu; Qingwen Huang; Huaxiu Shi; Lin Wang; Jianlin Ren
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  Interleukin-25 primed mesenchymal stem cells achieve better therapeutic effects on dextran sulfate sodium-induced colitis via inhibiting Th17 immune response and inducing T regulatory cell phenotype.

Authors:  Weizi Cheng; Jingling Su; Yiqun Hu; Qingwen Huang; Huaxiu Shi; Lin Wang; Jianlin Ren
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

Review 3.  Potential pre-activation strategies for improving therapeutic efficacy of mesenchymal stem cells: current status and future prospects.

Authors:  Meirong Li; Yufeng Jiang; Qian Hou; Yali Zhao; Lingzhi Zhong; Xiaobing Fu
Journal:  Stem Cell Res Ther       Date:  2022-04-04       Impact factor: 6.832
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.